Clinical Trial Update: Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 study assessing the efficacy and safety of combining repaglinide with insulin NPH in Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)
• insulin NPH (insulin NPH)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED